ribavirin has been researched along with bilirubin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.82) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 14 (41.18) | 29.6817 |
| 2010's | 15 (44.12) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cohen, A; Khakoo, R; Sigel, M; Togo, Y; Waldman, R | 1 |
| Gupta, P; Patki, SA | 1 |
| Charette, RP; Cooney, MK; Fox, JP; Hall, CE; Smith, CB | 1 |
| Abdulla, A; al-Sebayel, M; al-Traif, I; Hammad, A; Kizilisik, TA; Ramirez, CG | 1 |
| Gopal, DV; Rosen, HR | 1 |
| Fehér, J; Fehérvári, I; Görög, D; Kóbori, L; Lengyel, G; Nemes, B; Patonai, A; Perner, F; Sárváry, E; Varga, M | 1 |
| Delforge, ML; Deviere, J; Golstein, PE; Marcellin, P | 1 |
| Mukherjee, S | 1 |
| Blot, C; d'Arondel, C; Messous, D; Morra, R; Moussalli, J; Munteanu, M; Naveau, S; Poynard, T; Simon, A; Thibault, V | 1 |
| Bueso-Ramos, C; Chaves, J; Huen, A; Safdar, A; Vadhan-Raj, S | 1 |
| Brok, J; Gluud, C; Gong, Y; Koretz, RL | 1 |
| Bani-Sadr, F; Cacoub, P; Carrat, F; Denoeud, L; Lunel-Fabiani, F; Morand, P; Perronne, C; Pol, S | 1 |
| Forţofoiu, C; Genunche, A; Gofiţă, E; Streba, LA; Vere, CC | 1 |
| Figlerowicz, M; Kowala-Piaskowska, A; Mozer-Lisewska, I; Słuzewski, W | 1 |
| Llopis González, A; Márquez Peiró, JF; Morales Suárez-Varela, M; Pérez Peiró, C; Valero Alcocer, VE | 1 |
| Barreiro, P; González, M; Gonzalez-Lahoz, J; González-Pardo, G; Jiménez-Nácher, I; Morello, J; Rodríguez-Nóvoa, S; Soriano, V; Vispo, E | 1 |
| Lake-Bakaar, G | 1 |
| Berg, T; Dusheiko, G; Flisiak, R; Lenz, O; Manns, M; Marcellin, P; Meyvisch, P; Moreno, C; Peeters, M; Reesink, H; Sekar, V; Simmen, K; Verloes, R | 1 |
| Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA | 1 |
| Alessio, L; Coppola, N; Messina, V; Pasquale, G; Pisaturo, M; Sagnelli, C; Sagnelli, E; Stanzione, M; Starace, M | 1 |
| Bani-Sadr, F; Brodard, V; Ehrhard, F; Hentzien, M; Izopet, J; Lambert, D; Lebrun, D; Nguyen, Y; Peron, JM; Robbins, A; Tabary, T | 1 |
| Beumont-Mauviel, M; De La Rosa, G; Forns, X; Fried, MW; Fu, M; Jacobson, IM; Jessner, W; Kalmeijer, R; Lenz, O; Manns, MP; Ouwerkerk-Mahadevan, S; Peeters, M; Poordad, F; Scott, JA; Sinha, R; Zeuzem, S | 1 |
| Biziya, N; Gidaagaya, S; Namdag, B; Yang, SS | 1 |
| Hagiwara, H; Hamasaki, T; Harada, N; Hayashi, N; Hijioka, T; Hikita, H; Hiramatsu, N; Imai, Y; Inada, M; Inoue, A; Irishio, K; Ito, T; Katayama, K; Kato, M; Mita, E; Miyagi, T; Morishita, N; Oze, T; Sakamori, R; Tahata, Y; Takehara, T; Tamura, S; Tatsumi, T; Yakushijin, T; Yamada, R; Yamada, Y; Yoshida, Y; Yoshihara, H | 1 |
| Banhegyi, D; Bergin, C; Chernova, O; DeMasi, R; Doroana, M; Gori, A; Hadacek, B; Liu, C; Nelson, M; Rockstroh, JK; Verucchi, G | 1 |
| Kurmanova, GM; Kurmanova, KB; Sadykova, ShS | 1 |
| Cannizzaro, M; Cottone, M; Madonia, G; Madonia, S; Orlando, E; Stagno, B | 1 |
| Banerjee, D; Reddy, KR | 1 |
| Akushevich, L; Ben Ari, Z; Di Bisceglie, AM; Frazier, LM; Fried, MW; Kuo, A; Lim, JK; Lok, AS; Nelson, DR; Pockros, PJ; Shiffman, ML; Sulkowski, MS; Terrault, NA; Vainorius, M; Zeuzem, S | 1 |
| Bollipo, S; Cheng, W; Chivers, S; Dore, G; Fragomeli, V; Galhenage, S; Gazzola, A; George, J; Gow, P; Iser, D; Jones, T; Levy, M; Lubel, J; MacQuillan, G; Mitchell, JL; Nazareth, S; Pianko, S; Roberts, SK; Sasadeusz, J; Strasser, S; Stuart, KA; Thompson, A; Tse, E; Wade, A; Weltman, M; Wigg, A; Zekry, A | 1 |
| Bassiony, MAA; Hanafy, AS; Hussein, S; Mohamed, MS | 1 |
| De Maria, C; Ghidotti, I; Giannini, EG; Grillo, F | 1 |
| An, Y; Jia, L; Li, X; Liu, Q; Luo, G; Ouyang, J; Song, R; Zhang, B; Zhang, R | 1 |
2 review(s) available for ribavirin and bilirubin
| Article | Year |
|---|---|
Hepatology may have problems with putative surrogate outcome measures.
Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load | 2007 |
A PRISMA-compliant systematic review and meta-analysis of integrated Chinese and Western medicine in treating hepatitis C.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Combined Modality Therapy; Drug Therapy, Combination; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Medicine, Chinese Traditional; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Serum Albumin | 2020 |
9 trial(s) available for ribavirin and bilirubin
| Article | Year |
|---|---|
Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
Topics: Adult; Amantadine; Antibodies, Viral; Bilirubin; Body Temperature; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Male; Orthomyxoviridae; Placebos; Ribavirin; Ribonucleosides | 1976 |
Evaluation of ribavirin in the treatment of acute hepatitis.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Body Weight; Child; Clinical Trials as Topic; Double-Blind Method; Female; Hepatitis A; Humans; Male; Middle Aged; Ribavirin; Ribonucleosides | 1982 |
Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.
Topics: Administration, Oral; Bilirubin; Complement Fixation Tests; Double-Blind Method; Erythrocyte Count; Hemagglutination Inhibition Tests; Hematocrit; Hemoglobins; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukocyte Count; Male; Placebos; Platelet Count; Ribavirin; Ribonucleosides; Uric Acid | 1980 |
Hepatitis C recurrence in liver transplant recipients.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Recurrence; Ribavirin; RNA, Viral; Survival Rate; Time Factors | 1997 |
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers.
Topics: Alanine Transaminase; alpha-Macroglobulins; Antiviral Agents; Apolipoprotein A-I; Bilirubin; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Haptoglobins; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral | 2006 |
[Toxicity of the treatment of chronic hepatitis C with peginterferon alpha (2a or 2b) plus ribavirin in patients not previously treated].
Topics: Alanine Transaminase; Antiviral Agents; Bilirubin; Cohort Studies; Drug Therapy, Combination; Fatigue; Fever; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Viral Load | 2007 |
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bilirubin; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Heterocyclic Compounds, 3-Ring; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Simeprevir; Sulfonamides; Viral Load | 2011 |
The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin.
Topics: Aged; Antiviral Agents; Bilirubin; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hepatitis C, Chronic; Humans; Hyperbilirubinemia; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Pyrophosphatases; Recombinant Proteins; Ribavirin; Risk Factors; Simeprevir; Treatment Outcome | 2016 |
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bilirubin; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Oligopeptides; Ribavirin; RNA, Viral; Young Adult | 2015 |
23 other study(ies) available for ribavirin and bilirubin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite.
Topics: Antiviral Agents; Bilirubin; Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Remission Induction; Ribavirin; RNA, Viral; Viremia | 2003 |
[Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation].
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Severity of Illness Index; Treatment Outcome | 2003 |
Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; Creatine Kinase; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Muscular Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2004 |
Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Bilirubin; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2005 |
Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aerosols; Antiviral Agents; Bilirubin; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hodgkin Disease; Humans; Liver; Liver Function Tests; Ribavirin; Stem Cell Transplantation | 2006 |
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
Topics: Anti-HIV Agents; Antiviral Agents; Bilirubin; Chi-Square Distribution; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Multivariate Analysis; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Failure; Viral Load | 2007 |
Antiviral therapy effects upon hepatitis C cholestatic syndrome.
Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Cholestasis; Cholesterol; Drug Therapy, Combination; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leucyl Aminopeptidase; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Syndrome | 2007 |
Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; Child; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin.
Topics: Adult; Antiviral Agents; Atazanavir Sulfate; Bilirubin; Drug Interactions; Female; Glucuronosyltransferase; Hepacivirus; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Male; Middle Aged; Oligopeptides; Pyridines; Ribavirin | 2008 |
The effect of controlled therapy interruption in chronic HCV infection: enhanced host immune response? A hypothesis.
Topics: Alanine Transaminase; Antiviral Agents; Bilirubin; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin; Viral Load; Withholding Treatment | 2009 |
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load | 2012 |
Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Bilirubin; Biopsy; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Italy; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Young Adult | 2013 |
Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin.
Topics: Adult; Alanine Transaminase; Bilirubin; CD4 Lymphocyte Count; Hepatitis Antibodies; Hepatitis E; HIV Infections; Humans; Immunocompromised Host; Liver Function Tests; Male; Prothrombin Time; Ribavirin; RNA, Viral; Viral Load | 2014 |
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.
Topics: Anemia; Antiviral Agents; Bilirubin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Exanthema; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Neutropenia; Prevalence; Pruritus; Ribavirin; Simeprevir | 2015 |
Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene.
Topics: Bilirubin; Female; Glucuronosyltransferase; Hepatitis D, Chronic; Humans; Hyperbilirubinemia; Interferons; Male; Middle Aged; Ribavirin; Young Adult | 2015 |
[EFFECTS OF URSODEOXYCHOLIC ACID IN STANDART INTERFERONTHERAPY OF PATIENTS WITH CHRONIC HEPATITIS C AND B].
Topics: Adult; Alkaline Phosphatase; Bilirubin; Female; gamma-Glutamyltransferase; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2015 |
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
Topics: Bilirubin; Gilbert Disease; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Ribavirin | 2016 |
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir? Authors' reply.
Topics: Bilirubin; Gilbert Disease; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Ribavirin | 2016 |
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Bilirubin; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ribavirin; Risk Factors; Serum Albumin; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Failure; Uridine Monophosphate; Young Adult | 2016 |
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Function Tests; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2017 |
Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carbamates; Drug Therapy, Combination; Egypt; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; International Normalized Ratio; Male; Middle Aged; Platelet Count; Prospective Studies; Pyrrolidines; Ribavirin; Serum Albumin; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Valine | 2017 |
Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carbamates; Female; gamma-Globulins; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Imidazoles; Liver; Liver Cirrhosis; Middle Aged; Pyrrolidines; Ribavirin; RNA, Viral; Serum Albumin; Sofosbuvir; Valine; Viral Load | 2019 |